Is MNKD stock safe? | Glauxie AI

Q: Is MNKD stock safe?

MannKind Corporation (MNKD) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Michael E. Castagna. MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It... Employees: 592.

Q: What are the risks of investing in MNKD?

Identify key risks of investing in MNKD — debt, competition, volatility, and sector headwinds.

Q: Is MNKD a good long-term investment?

Evaluate MNKD as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does MNKD have?

Review MNKD total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is MNKD stock safe?

🦉

MannKind Corporation (MNKD)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOMichael E. Castagna

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also...

Key Executives

Name	Title
Ajay Ahuja	Executive VP & Chief Medical Officer
Christopher Prentiss	Chief Financial Officer
David Thomson	Executive Vice President, General Counsel & Secretary
Dominic Marasco	President of Endocrine Business Unit
Michael E. Castagna	Chief Executive Officer & Director
Sanjay Singh	Executive Vice President of Technical Operations

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

MNKD Profile Financials

What are the risks of investing in MNKD? Is MNKD a good long-term investment? How much debt does MNKD have?